Vericiguat in Heart Failure with Reduced Ejection Fraction

N Engl J Med. 2020 Oct 8;383(15):1496-1497. doi: 10.1056/NEJMc2027731.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Heart Failure*
  • Heterocyclic Compounds, 2-Ring*
  • Humans
  • Pyrimidines
  • Stroke Volume

Substances

  • Heterocyclic Compounds, 2-Ring
  • Pyrimidines
  • vericiguat